Annual Operating Expenses
$44.72 M
-$27.79 M-38.33%
December 31, 2023
Summary
- As of February 12, 2025, PRQR annual total operating expenses is $44.72 million, with the most recent change of -$27.79 million (-38.33%) on December 31, 2023.
- During the last 3 years, PRQR annual operating expenses has fallen by -$3.67 million (-7.58%).
- PRQR annual operating expenses is now -38.33% below its all-time high of $72.51 million, reached on December 31, 2022.
Performance
PRQR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$13.96 M
+$3.13 M+28.90%
September 1, 2024
Summary
- As of February 12, 2025, PRQR quarterly total operating expenses is $13.96 million, with the most recent change of +$3.13 million (+28.90%) on September 1, 2024.
- Over the past year, PRQR quarterly operating expenses has increased by +$4.43 million (+46.39%).
- PRQR quarterly operating expenses is now -33.07% below its all-time high of $20.86 million, reached on September 30, 2022.
Performance
PRQR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PRQR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.3% | +46.4% |
| 3 y3 years | -7.6% | -33.1% |
| 5 y5 years | +3.8% | -33.1% |
PRQR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.3% | at low | -33.1% | +46.4% |
| 5 y | 5-year | -38.3% | at low | -33.1% | +46.4% |
| alltime | all time | -38.3% | +939.5% | -33.1% | +1094.5% |
ProQR Therapeutics NV Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.96 M(+28.9%) |
| Jun 2024 | - | $10.83 M(-20.4%) |
| Mar 2024 | - | $13.60 M(+1.2%) |
| Dec 2023 | $44.72 M(-38.3%) | $13.44 M(+40.9%) |
| Sep 2023 | - | $9.54 M(-13.0%) |
| Jun 2023 | - | $10.96 M(+1.6%) |
| Mar 2023 | - | $10.79 M(-20.0%) |
| Dec 2022 | $72.51 M(+4.7%) | $13.48 M(-35.4%) |
| Sep 2022 | - | $20.86 M(+16.2%) |
| Jun 2022 | - | $17.96 M(-11.9%) |
| Mar 2022 | - | $20.39 M(+6.6%) |
| Dec 2021 | $69.27 M(+43.2%) | $19.13 M(+3.3%) |
| Sep 2021 | - | $18.53 M(+11.0%) |
| Jun 2021 | - | $16.70 M(+14.5%) |
| Mar 2021 | - | $14.58 M(+4.8%) |
| Dec 2020 | $48.39 M(-24.8%) | $13.91 M(+7.0%) |
| Sep 2020 | - | $13.00 M(-1.9%) |
| Jun 2020 | - | $13.25 M(-27.1%) |
| Mar 2020 | - | $18.19 M(+3.2%) |
| Dec 2019 | $64.31 M | $17.62 M(+17.9%) |
| Sep 2019 | - | $14.95 M(+12.5%) |
| Jun 2019 | - | $13.30 M(-20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $16.74 M(+70.7%) |
| Dec 2018 | $43.06 M(-7.5%) | $9.81 M(+42.5%) |
| Sep 2018 | - | $6.88 M(-33.3%) |
| Jun 2018 | - | $10.32 M(-18.9%) |
| Mar 2018 | - | $12.72 M(+4.2%) |
| Dec 2017 | $46.57 M(+5.8%) | $12.21 M(+4.1%) |
| Sep 2017 | - | $11.73 M(+3.6%) |
| Jun 2017 | - | $11.32 M(+2.8%) |
| Mar 2017 | - | $11.01 M(+16.9%) |
| Dec 2016 | $44.01 M(+46.6%) | $9.42 M(-18.3%) |
| Sep 2016 | - | $11.52 M(-4.5%) |
| Jun 2016 | - | $12.06 M(+23.5%) |
| Mar 2016 | - | $9.77 M(+68.3%) |
| Dec 2015 | $30.02 M(+37.1%) | $5.80 M(-30.0%) |
| Sep 2015 | - | $8.29 M(+16.2%) |
| Jun 2015 | - | $7.13 M(-10.7%) |
| Mar 2015 | - | $7.99 M(+29.1%) |
| Dec 2014 | $21.89 M(+408.9%) | $6.19 M(-3.4%) |
| Sep 2014 | - | $6.41 M(-2.8%) |
| Jun 2014 | - | $6.59 M(+158.7%) |
| Mar 2014 | - | $2.55 M(+24.9%) |
| Dec 2013 | $4.30 M | $2.04 M(+74.5%) |
| Sep 2013 | - | $1.17 M |
FAQ
- What is ProQR Therapeutics NV annual total operating expenses?
- What is the all time high annual operating expenses for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual operating expenses year-on-year change?
- What is ProQR Therapeutics NV quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly operating expenses year-on-year change?
What is ProQR Therapeutics NV annual total operating expenses?
The current annual operating expenses of PRQR is $44.72 M
What is the all time high annual operating expenses for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual total operating expenses is $72.51 M
What is ProQR Therapeutics NV annual operating expenses year-on-year change?
Over the past year, PRQR annual total operating expenses has changed by -$27.79 M (-38.33%)
What is ProQR Therapeutics NV quarterly total operating expenses?
The current quarterly operating expenses of PRQR is $13.96 M
What is the all time high quarterly operating expenses for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly total operating expenses is $20.86 M
What is ProQR Therapeutics NV quarterly operating expenses year-on-year change?
Over the past year, PRQR quarterly total operating expenses has changed by +$4.43 M (+46.39%)